Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUTL is expected to report earnings to fall 16.56% to -22 cents per share on July 30

Autolus Therapeutics AUTL Stock Earnings Reports

Q2'26

Est.

$-0.23

Q1'26

Missed

by $0.02

Q4'25

Missed

by $0.09

Q3'25

Missed

by $0.08

Q2'25

Beat

by $0.05

The last earnings report on May 14 showed earnings per share of -27 cents, missing the estimate of -25 cents. With 844.82K shares outstanding, the current market capitalization sits at 401.85M.

View a ticker or compare two or three

Compare

AUTL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AUTL